dissolution rate e-tongue hot melt extrusion hydrophilic polymers itraconazole palatability a b s t r a c t This work aimed at obtaining an optimized itraconazole (ITZ) solid oral formulation in terms of palatability and dissolution rate by combining different polymers using hot melt extrusion (HME), according to a simplex centroid mixture design. For this, the polymers Plasdone
Introduction
Advantages of oral solid formulations are clear: high stability, dose accuracy, low production, and transportation costs, besides patient compliance.
1 Still, unsatisfactory physicochemical properties may compromise drug bioavailability. It is estimated that 75% of drug candidates to give rise to new medicines are poorly water soluble. 2 Such low solubility negatively affects pharmacokinetics, causing high rates of failure in clinical trials, which has considerably reduced the number of innovative medicines that reaches the market over the years. 3 Other challenge for oral delivery is the unpleasant taste of drugs, which adversely influences patient compliance, especially when dealing with children and elderly.
4
Most active pharmaceutical ingredients present bitter taste. Thus, considering the wide variety of bitter receptors on the tongue, camouflaging drugs unpleasant taste is not a trivial task.
5
Hot melt extrusion (HME) is a technological process for developing solid dispersions that has been capable of improving dissolution rates of many poorly water-soluble drugs.
6,7 Remarkable advantages of this technique include avoidance of organic solvents, possibility of continuous manufacturing, easy processing scale-up, and entrudate uniformity due to the high shear mixing capacity. Indeed, such a high mixing capacity provides a high drug-polymer interaction degree and, with the adequate formulation, bitter taste can be masked as polymers interact with tongue taste receptors masking the drug.
Despite all these advantages, a still limited number of HME pharmaceutical products are available on the market, around 15 products.
8 A possible explanation is the complexity of experimental variables involved in the development of products by HME, which may compromise overall process robustness (mainly, the use of different temperatures throughout extrusion course and sample residence time into the system). Additionally, small fluctuations in formulation composition can cause important changes in their properties. Evidently, all these factors raise quality issues, especially in large-scale production.
9
Quality-by-design tools such as mixture designs are useful to rationalize the experimental work in order to establish the optimum formulation composition by determining a design space in which the components can fluctuate without impairing their functional characteristics, thus facilitating the scale-up process. Better yet, such approach also allows finding regions in the experimental space where the levels of formulation factors possibly provide the best performance. 10 Therefore, this work evaluated a simplex centroid mixture design experiment as a tool for predicting the best polymer combination for HME of a bitter insoluble drug. The goal was to obtain the best formulation for HME with improved characteristics, specifically, palatability and dissolution rate, by simply selecting the better suited excipients, while maintaining the most simple process parameters: constant temperature and no recirculation. For this, itraconazole (ITZ) was selected as drug model, because it is a BCS II compound possessing a pronounced bitter taste and promising results when processed by HME. 
HME Extrudates
Extrudates were prepared by HME combining ITZ with 3 polymers (PVP/VA, HPC, and SOL) following a simplex centroid mixture design without constraints (in detail in section Design of Experiment). For this, ITZ concentration was fixed at 25% w/w in each sample (Table 1) . Physical mixtures of each formulation were prepared using a mortar and were then extruded using constant temperature without sample recirculation in a Pharma Mini HME (ThermoScientific). Extrusion parameters, temperature and rotation speed, were set with the purpose of obtaining an adequate extrusion flow and translucent extrudates without darkening (Table 1) . Extrudates were milled in a knife mill and the fractions were separated using sieves with different mesh. After separation, a powder fraction having a size ranging from 180 to 125 mm, which was the fraction with the best yield, was selected for further tests.
Characterization Assays Drug Determination
A spectrophotometric method using a UV-VIS Lambda XLS spectrophotometer (PerkinElmer) set at 255 nm was developed for ITZ determination in formulations and in dissolution rate experiments. Analytical method was validated. Selectivity against polymers was evaluated and no statistical interference with excipients was detected (Student t-test, p ¼ 0.07). Linearity correlation coefficient (CC) was 0.9984 with slope different from zero and residues randomly distributed without tendency.
Morphological Analysis
Morphological characteristics of the individual compounds, physical mixtures, and extrudates were assessed with a stereoscope (Laborana/SZdSZT, China) and with a scanning electron microscope (JSM-7001F; Jeol, Akishima, Japan), in which the samples were previously metallized with gold. 
